Regulatory News: The Japanese Ministry for Health, Labor and Welfare, MHLW, has given
approval for Leksell Gamma Knife® Perfexionâ„¢
the world-leading clinical solution for non-invasive radiosurgical
treatments of tumors, vascular malformations and other brain disorders.
Elekta, the international medical technology group and developer of
Gamma Knife® surgery, will now be able to
deliver and install this advanced technology at new and existing
customer sites in Japan. Gamma Knife surgery has become the world´s
most widely used radiosurgery treatment due to its extraordinary
accuracy, reduction of excess radiation dose to the body, extensive
history and clinical documentation. Unlike other systems, invoking
compromises in order to be able to treat the whole body, Leksell Gamma
Knife is specifically designed to optimize treatment to the head and
neck area "“ a fact appreciated by
neurosurgeons and patients alike. Launched by Elekta in 2006 and now in clinical use in over 30 locations
around the world, Leksell Gamma Knife Perfexion combines the proven
precision of the revolutionary Leksell Gamma Knife, with a dramatic
increase in clinical reach to treat a wider range of targets faster and
more efficiently than ever before. The system´s
unique geometric and dosimetric design robotically administers thousands
of beams of low-intensity radiation that converge to deliver a single
therapeutic dose of radiation with pin-point accuracy to the most
difficult targets; while integrated treatment planning and delivery
streamlines the radiosurgery process to treat even multiple brain
lesions in a single automated procedure. Over 50 centers in Japan are currently offering Gamma Knife surgery to
patients with benign or malignant brain tumors, vascular malformations
and certain functional brain disorders. Several of these have already
expressed interest in upgrading their facility to Leksell Gamma Knife
Perfexion. At the recent International Leksell Gamma Knife® Society Meeting on May 18-22, in Quebec, Canada, a large number of
Japanese neurosurgeons and other clinicians attended and was presented
with clinical data from the current users of Leksell Gamma Knife
Perfexion. About Elekta Elekta is an international medical technology group, providing
oncologists, radiation therapists, neurosurgeons and many other medical
specialists with state of the art tools to fight serious disease. Elekta provides advanced clinical solutions, comprehensive management
and information systems as well as services for improved cancer care and
management of brain disorders. Elekta´s systems and solutions are used in
over 5,000 hospitals around the world. Clinical and information
management solutions include, among others, Leksell Gamma Knife® for non-invasive treatment of brain disorders, Elekta Axesseâ„¢ and Elekta Synergy® for stereotactic and image
guided radiation therapy and radiosurgery as well as the MOSAIQâ„¢ suite of software for image-enabled EMR and efficient management of
clinical and patient data. With over 2,500 employees globally, the corporate headquarter is located
in Stockholm, Sweden and the company is listed on the Nordic Exchange
under the ticker EKTAb. More information about Elekta can be found at www.elekta.com. This information was brought to you by Cision http://newsroom.cision.com
